EcoDrugPlus

Ensembl ID : WBGene00225321
Gene Symbol: WBGENE00225321
4 External references
218 Possible Orthologues:

Ensembl ID : WBGene00225348
Gene Symbol: WBGENE00225348
4 External references
882 Possible Orthologues:

Ensembl ID : WBGene00225395
Gene Symbol: WBGENE00225395
4 External references
329 Possible Orthologues:

Ensembl ID : WBGene00225424
Gene Symbol: WBGENE00225424
2 External references
755 Possible Orthologues:

Ensembl ID : WBGene00225467
Gene Symbol: WBGENE00225467
6 External references
329 Possible Orthologues:

Ensembl ID : WBGene00225471
Gene Symbol: WBGENE00225471
4 External references
1222 Possible Orthologues:

Ensembl ID : WBGene00225490
Gene Symbol: WBGENE00225490
3 External references
236 Possible Orthologues:

Ensembl ID : WBGene00225501
Gene Symbol: WBGENE00225501
6 External references
209 Possible Orthologues:

Ensembl ID : WBGene00225509
Gene Symbol: WBGENE00225509
6 External references
100 Possible Orthologues:

Ensembl ID : WBGene00225530
Gene Symbol: WBGENE00225530
6 External references
148 Possible Orthologues:

Ensembl ID : WBGene00225556
Gene Symbol: WBGENE00225556
2 External references
342 Possible Orthologues:

Ensembl ID : WBGene00220320
Gene Symbol: WBGENE00220320
3 External references
1193 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).